By Allison MacAlister CCSN Communications & Social Media Coordinator On March 6th 2018, the DNA test company 23andMe announced that it now has approval to tell customers of their mail-in DNA-testing kit about three gene mutations of BRCA1 and BRCA2 as part of their genetic health results. What does that mean, and is it worth being concerned about? Let’s talk about the facts. Gene mutations?
Browse Posts by Tag
Access Action Advocacy Asbestos Awareness Biosimilars Breast Cancer Canada Canadian Cancer Survivor Network Cancer Cancer Care Cancer Prevention Cancer Survivors CAPO Caregiving CCSNPoli CdnPoli Cost Drug Approval Election Guest Post Health Healthcare Insurance Jackie Manthorne Lung Cancer Mammogram Medical Cannabis Medical Marijuana Melanoma Mesothelioma Metastatic Breast Cancer Metastatic Cancer Metastatic Prostate Cancer Nova Scotia Oncology OnPoli Ontario Ottawa Patients PCPA Prostate Cancer Research Survey Survivor